Xcyte Therapies, Inc.
United States
acquired
acquired
Stage
About
Xcyte Therapies develops immune therapies for cancer treatment. The company merged with Cyclacel Group plc.
Explore Xcyte Therapies, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.